Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fractalkine/CX3CL1: a potential new target for inflammatory diseases.

Literature DB >> 21045240

Fractalkine/CX3CL1: a potential new target for inflammatory diseases.

Brian A Jones¹, Maria Beamer, Salahuddin Ahmed.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2010 PMID： 21045240 PMCID： PMC3002219 DOI： 10.1124/mi.10.5.3

Source DB: PubMed Journal: Mol Interv ISSN： 1534-0384

× No keyword cloud information.

58 in total

1. Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression.

Authors: Sophie Faure; Laurence Meyer; Emmanuelle Genin; Philippe Pellet; Patrice Debré; Ioannis Théodorou; Christophe Combadière
Journal: J Acquir Immune Defic Syndr Date: 2003-03-01 Impact factor: 3.731

2. Fractalkine expression in human renal inflammation.

Authors: Paul Cockwell; Srabasti J Chakravorty; John Girdlestone; Caroline O S Savage
Journal: J Pathol Date: 2002-01 Impact factor: 7.996

3. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.

Authors: Toshihiro Nanki; Toshio Imai; Kenji Nagasaka; Yasuyo Urasaki; Yoshinori Nonomura; Ken Taniguchi; Kenji Hayashida; Jun Hasegawa; Osamu Yoshie; Nobuyuki Miyasaka
Journal: Arthritis Rheum Date: 2002-11

4. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

Authors: K J Garton; P J Gough; C P Blobel; G Murphy; D R Greaves; P J Dempsey; E W Raines
Journal: J Biol Chem Date: 2001-08-08 Impact factor: 5.157

5. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

Authors: Christian Hundhausen; Dominika Misztela; Theo A Berkhout; Neil Broadway; Paul Saftig; Karina Reiss; Dieter Hartmann; Falk Fahrenholz; Rolf Postina; Vance Matthews; Karl-Josef Kallen; Stefan Rose-John; Andreas Ludwig
Journal: Blood Date: 2003-04-24 Impact factor: 22.113

6. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

Authors: Christophe Combadière; Stéphane Potteaux; Ji-Liang Gao; Bruno Esposito; Saveria Casanova; Eric J Lee; Patrice Debré; Alain Tedgui; Philip M Murphy; Ziad Mallat
Journal: Circulation Date: 2003-02-25 Impact factor: 29.690

Review 7. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.

Authors: Federica Marchesi; Marco Locatelli; Graziella Solinas; Marco Erreni; Paola Allavena; Alberto Mantovani
Journal: J Neuroimmunol Date: 2010-07-13 Impact factor: 3.478

8. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression.

Authors: Miyuki Nishimura; Hisanori Umehara; Takashi Nakayama; Osamu Yoneda; Kunio Hieshima; Mayumi Kakizaki; Naochika Dohmae; Osamu Yoshie; Toshio Imai
Journal: J Immunol Date: 2002-06-15 Impact factor: 5.422

9. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

Authors: Philippe Lesnik; Christopher A Haskell; Israel F Charo
Journal: J Clin Invest Date: 2003-02 Impact factor: 14.808

10. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.

Authors: Petronela Ancuta; Ravi Rao; Ashlee Moses; Andrew Mehle; Sunil K Shaw; F William Luscinskas; Dana Gabuzda
Journal: J Exp Med Date: 2003-06-16 Impact factor: 14.307

77 in total

1. Photobiomodulation-induced analgesia in experimental temporomandibular disorder involves central inhibition of fractalkine.

Authors: João Ignácio Ferrara-Jr; Everton Tiago de Souza; Adriano Cardozo Franciosi; Elaine Flamia Toniolo; Camila Squarzoni Dale
Journal: Lasers Med Sci Date: 2019-04-10 Impact factor: 3.161

2. Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation.

Authors: B Dedeoglu; A E de Weerd; L Huang; A W Langerak; F J Dor; M Klepper; W Verschoor; D Reijerkerk; C C Baan; N H R Litjens; M G H Betjes
Journal: Clin Exp Immunol Date: 2017-02-28 Impact factor: 4.330

3. Tefillin use induces remote ischemic preconditioning pathways in healthy men.

Authors: A Phillip Owens; Nathan Robbins; Keith Saum; Shannon M Jones; Akiva Kirschner; Jessica G Woo; Connie McCoy; Samuel Slone; Marc E Rothenberg; Elaine M Urbina; Michael Tranter; Jack Rubinstein
Journal: Am J Physiol Heart Circ Physiol Date: 2018-09-14 Impact factor: 4.733

Fractalkine/CX3CL1: a potential new target for inflammatory diseases.

1. Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression.

2. Fractalkine expression in human renal inflammation.

3. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.

4. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

5. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

6. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

Review 7. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.

8. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression.

9. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

10. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.

1. Photobiomodulation-induced analgesia in experimental temporomandibular disorder involves central inhibition of fractalkine.

2. Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation.

3. Tefillin use induces remote ischemic preconditioning pathways in healthy men.

Review 4. Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

5. Neuroprotective fractalkine in fetal alcohol syndrome.

6. PGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen.

7. NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification.

Review 8. The role of CX3CL1 in fetal-maternal interaction during human gestation.

Review 9. The immune system and developmental programming of brain and behavior.

10. Clinicopathological significance of serum fractalkine in primary biliary cirrhosis.